AlphAIalphai — Financial news for AI agents
tradingview.comJUL 311 min read$VMD

VMD Q2'26 Earnings: EPS estimate is 0.12 USD

Viemed Healthcare, Inc. (VMD) is scheduled to report Q2 2026 earnings on Aug. 3 at 8:00 AM ET. The consensus outlook cited for Q2 2026 calls for revenue of $78.0 million and EPS of $0.12, with figures stated in USD.

Original reporting
tradingview.com
Published Jul 31, 2026, 11:00 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 31, 2026, 9:11 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
VMD Q2'26 Earnings: EPS estimate is 0.12 USD — source image
Source · tradingview.com
Decision brief

The 30-second read

$VMDNeutralMed
01

Why it matters

Traders can use the consensus $78.0M revenue and $0.12 EPS to frame expectations and scenario-plan for upside/downside into the Aug 3 release.

02

Market read

Provides a concrete earnings date and consensus figures that can guide positioning and options/volatility expectations into the print.

03

What to watch

The article does not include management guidance, backlog, or any risk factors, which are often the true drivers of post-earnings repricing.

Relevance 5/10Novelty 5/10Timing: ahead of Aug 3 pre-market earnings release

Background

The piece is a pre-announcement note for VMD’s upcoming Q2'26 earnings, including consensus revenue and EPS.

Company-level read

Ticker impact

$VMDNeutralMedium confidence
Context

VMD is scheduled to announce Q2'26 results on Aug 3, with consensus revenue of $78.0M and EPS of $0.12.

Expected impact

Moderate volatility possible into Aug 3 as traders position around the $78.0M revenue and $0.12 EPS consensus.

Evidence & confidence

The article provides only the scheduled earnings date and consensus estimates, with no surprise datapoint beyond what traders typically price in ahead of results.

Market effects

Sector

Limited sector read-through because the article contains only company-specific consensus estimates.

Regional

No explicit regional market linkage provided.

Global

No global macro or cross-border catalyst mentioned.

Counterpoint

What could challenge this read

If VMD’s actual results diverge materially from the $78.0M/$0.12 consensus, the stock reaction could be driven more by guidance and margins than by the headline EPS.

Key entities

  • company
    VMD

    Viemed Healthcare, Inc., scheduled to report Q2'26 results on Aug 3 with consensus estimates provided.

Read at source← All news

Related articles

AUG 6
$VMDMedAI 8/10

Viemed Healthcare Q2 Earnings Call Highlights

Viemed Healthcare (NASDAQ:VMD) reported Q2 updates on home respiratory and sleep therapies. Management cited improved ventilator patient growth and said PAP setups rose, with sleep patients up about 5% sequentially and 44% YoY. Equipment sales nearly doubled to $19M. Gross profit was $45M (57.7% margin). Full-year net revenue guidance raised to $314M-$320M and adjusted EBITDA to $64M-$68M.

yahoo.com6 min
AUG 3
$VMDHigh

VIEMED HEALTHCARE, INC. (VMD): Results of Operations and Financial Condition

VIEMED HEALTHCARE, INC. (VMD) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 q22026earningsrelease.htm EX-99.1 Document VIEMED HEALTHCARE ANNOUNCES SECOND QUARTER 2026 FINANCIAL RESULTS Lafayette, Louisiana (August 3, 2026) Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD), a national provider of technology-enabled, home-based hea

SEC EDGAR 8-K6 min
AUG 8
$RIVNMed

What Rivian And Lucid's Latest Earnings Say About The EV Startup Race

The article compares Rivian and Lucid after their 2021 IPOs, focusing on recent earnings. Lucid reported $405 million revenue in the quarter, with net loss widening to over $1 billion, and announced an “operational reset” tied to $1.4 billion cash savings in 2026, plus $3 billion liquidity. Rivian reported $1.66 billion revenue last quarter and raised 2026 delivery guidance to 65,000-70,000 vehicles.

insideevs.com6 min
AUG 8
$LNGMedAI 8/10

Cheniere Energy Q2 Earnings Call Highlights

Cheniere Energy’s Q2 earnings call said updated guidance includes about $300 million from additional expected production, with Corpus Christi Stage 3 over 98% complete and Train 7 entering commissioning. The company signed a roughly $4.7 billion EPC contract for Sabine Pass Phase I, targeting FID in early next year. Cheniere repurchased 2.2 million shares for $550 million and declared a $0.555 dividend.

yahoo.com6 min
AUG 8
$CCMed

Why Chemours Plunged on Wednesday

Chemours (NYSE: CC) shares fell 18.7% after its Q2 earnings. The company reported slight revenue decline and adjusted EPS of $0.42, down 31% year over year, meeting expectations. Management cited lower Optane refrigerant sales due to supply-chain inventory and the wind-down of the SPS Capstone business. Full-year growth guidance remains 1% to 5%.

aol.com6 min